The role of melatonin in preventing amiodarone-induced rat liver damage
Canadian Journal of Physiology and Pharmacology · 2024
DOI: 10.1139/cjpp-2023-0253 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Journal of Physiology and Pharmacology, 2024. Verfasst von Dejan Petrović und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Institute for Treatment and Rehabilitation, University of Niš, Niška Banja, Niš, Serbia. Hauptthemen laut MEDLINE: Amiodarone, Melatonin, Rats, Wistar, Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja.
Abstract (Originalsprache)
Long-term exposure to amiodarone, an antiarrhythmic drug, can induce different organ damage, including liver. Cell damage included by amiodarone is a consequence of mitochondrial damage, reactive oxygen species production, and cell energy depletion leading to programmed cell death. In the present study, hepatoprotective potential of neurohormone melatonin (50 mg/kg/day) was evaluated in a chronic experimental model of liver damage induced by a 4-week application of amiodarone (70 mg/kg/day). The obtained results indicate that amiodarone induces an increase in xanthine oxidase activity, as well as the content of the lipid and protein oxidatively modified products and p53 levels. Microscopic analysis further corroborated the biochemical findings revealing hepatocyte degeneration, apoptosis, and occasional necrosis, with the activation of Kupffer cells. Coadministration of melatonin and amiodaron prevented an increase in certain damage associated parameters, due to its multiple targets. In conclusion, the application of melatonin together with amiodarone prevented an increase in tissue oxidative damage parameters and moderately prevented liver cell apoptosis, indicating that the damage of hepatocytes provoked by amiodarone supersedes the protective properties of melatonin in a given dose.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, Institute for Treatment and Rehabilitation, University of Niš, Niška Banja, Niš, Serbia.
- Institute for Treatment and Rehabilitation, University of Niš, Niška Banja, Niš, Serbia.
- Institute of Pathology, University Clinical Centre Niš, Niš, Serbia.
- Department of Obstetrics and Gyanaecology, Faculty of Medicine, University of Pristina, Kosovska Mitrovica, Serbia.
- Dom zdravlja Medveđa, Šetalište 5, 16240 Medveđa, Serbia.
- Department of Biochemistry, Faculty of Medicine, University of Niš, Niš, Serbia.
ORCID-Profile: Dušan T Sokolović
Förderung
- Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja
Zitieren
APA
Petrović, D., Ilić, M. D., Simonović, D., Stojanović, M., Stanković, M., Stanišić, S., Stojanović, S., Arsić, N., & Sokolović, D. T. (2024). The role of melatonin in preventing amiodarone-induced rat liver damage. Canadian Journal of Physiology and Pharmacology. https://doi.org/10.1139/cjpp-2023-0253
Vancouver
Petrović D, Ilić MD, Simonović D, Stojanović M, Stanković M, Stanišić S, et al. The role of melatonin in preventing amiodarone-induced rat liver damage. Canadian Journal of Physiology and Pharmacology. 2024. doi:10.1139/cjpp-2023-0253
BibTeX
@article{Petrovi2024,
author = {Petrović, Dejan and Ilić, Marina Deljanin and Simonović, Dejan and Stojanović, Milovan and Stanković, Milica and Stanišić, Slaviša and Stojanović, Sanja and Arsić, Nebojša and Sokolović, Dušan T},
title = {The role of melatonin in preventing amiodarone-induced rat liver damage},
journal = {Canadian Journal of Physiology and Pharmacology},
year = {2024},
doi = {10.1139/cjpp-2023-0253}
}
EUVIMED